If you are wondering whether Organon’s current share price reflects its true worth, this article will walk through what the numbers actually say about the stock’s value. Organon last closed at US$7.29 ...

In the latest trading session, Organon (OGN) closed at $9.28, marking a -1.07% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.53%. At the same time, the ...

The average one-year price target for Organon (NYSE:OGN) has been revised to $9.86 / share. This is a decrease of 10.77% from the prior estimate of $11.05 dated November 7, 2025. The price target is ...

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars ...

Organon reported a disappointing Q4, with revenue down 5% YoY and significant weakness in Women's Health. Find out why OGN stock is a hold.

Amphastar Pharmaceuticals is up 8.2% since the beginning of the year, but at $28.63 per share, it is still trading 11.3% below its 52-week high of $32.29 from February 2025. Investors who bought ...